Pre-operative Tamsulosin and Time to Spontaneous Void After Hysterectomy

• Status: Recruiting
• Trial end date: 2022-06-30
• Target enrollment: 0
• Participant gender: Female

Summary

The aim of this study is to determine if a one time dose of tamsulosin given pre-operatively decreases the time to void and the time to discharge after minimally invasive hysterectomy.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Arizona
• Treatments: Tamsulosin

Criteria

Inclusion Criteria:

• Women 18-80 undergoing outpatient minimally invasive hysterectomy

Exclusion Criteria:

• Inability to provide informed consent

• Bladder malignancy

• Intra-operative bladder or ureteral injury; anticipated prolonged bladder catheterization

• Plan for sling or anterior repair